Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 2, 2013

View Archived Issues

Lacer prepares new strontium salts for osteoporosis

New autotaxin inhibitors claimed by Bristol-Myers Squibb

Progen Pharmaceuticals signs license term sheet for PG-545

Special protocol assessment agreement reached for phase III AEZS-108 trial

Synergy Pharmaceuticals' GC-C agonist SP-333 completes phase I trial

Emergent BioSolutions acquires rights to pandemic influenza vaccine candidate

Phase IIb trial begins for plecanatide in IBS-C

Proteome Sciences' CKI-delta inhibitors improve cognition in Alzheimer's disease model

Targeting MALT1 as a therapeutic approach for ABC-DLBCL

AI-10-49 proves effective in murine leukemia model

In vivo profiling of mGlu5 receptor modulators

Hutchison MediPharma presents novel SYK inhibitors

Swiss researchers present new antibacterial prodrugs

New beta-amyloid ligands disclosed by Italian researchers

CT Atlantic and the Universitat Zurich patent novel antibodies for cancer

Affectis Pharmaceuticals synthesizes novel P2X7 receptor antagonists

New compound demonstrates efficacy in KSHV-associated primary effusion lymphoma

New hydrid cholinesterase inhibitors divulged by Polish team

Chugai Pharmaceutical develops novel bispecific antibody for hemophilia

Xoma to study gevokizumab for noninfectious anterior scleritis

FDA grants accelerated approval for Sirturo in tuberculosis

Data presented from phase Ib trial of a ghrelin receptor agonist for type 2 diabetes

Evotec and Apeiron Biologics establish cancer immunotherapy collaboration

Third milestone in Vernalis' drug discovery collaboration with Lundbeck

FDA approves Fulyzaq for diarrhea in patients with HIV/AIDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...